Anti-p53 antibody [PAb 240] (ab26) is a mouse monoclonal antibody detecting p53 in Western Blot, IP, ICC/IF. Suitable for Human, Mouse.
- KO validated for confirmed specificity
- Over 400 publications
- Trusted since 1998
pH: 7.4
Preservative: 0.02% Sodium azide
Constituents: PBS, 6.97% L-Arginine
IP | WB | ICC/IF | |
---|---|---|---|
Human | Tested | Tested | Tested |
Mouse | Tested | Tested | Tested |
Rat | Predicted | Predicted | Predicted |
Chinese hamster | Predicted | Predicted | Predicted |
Cow | Predicted | Predicted | Predicted |
Dog | Predicted | Predicted | Predicted |
Monkey | Predicted | Predicted | Predicted |
Syrian hamster | Predicted | Predicted | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat, Cow, Dog, Monkey, Chinese hamster, Syrian hamster | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1.00000-5.00000 µg/mL | Notes Please note that expression of target protein may be very low without stimulation/treatment (e.g. DNA damaging agent). We recommend using 3% milk as the blocking agent for Western blot. |
Species Mouse | Dilution info 1.00000-5.00000 µg/mL | Notes Please note that expression of target protein may be very low without stimulation/treatment (e.g. DNA damaging agent). We recommend using 3% milk as the blocking agent for Western blot. |
Species | Dilution info | Notes |
---|---|---|
Species Rat, Cow, Dog, Monkey, Chinese hamster, Syrian hamster | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 0.50000-1.00000 µg/mL | Notes - |
Species Mouse | Dilution info 0.50000-1.00000 µg/mL | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat, Cow, Dog, Monkey, Chinese hamster, Syrian hamster | Dilution info - | Notes - |
Select an associated product type
Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed:19556538, PubMed:20673990, PubMed:22726440). Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Negatively regulates cell division by controlling expression of a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (By similarity). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (By similarity). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression (By similarity). Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis, but seems to have to effect on cell-cycle regulation. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492).
P53, Trp53, Tp53, Cellular tumor antigen p53, Tumor suppressor p53
Anti-p53 antibody [PAb 240] (ab26) is a mouse monoclonal antibody detecting p53 in Western Blot, IP, ICC/IF. Suitable for Human, Mouse.
- KO validated for confirmed specificity
- Over 400 publications
- Trusted since 1998
pH: 7.4
Preservative: 0.02% Sodium azide
Constituents: PBS, 6.97% L-Arginine
ab26 has been knockout validated in Western blot. The expected band was seen in wild type HCT116 cells treated with the DNA damaging agent irinotecan and no band was seen in TP53 knockout HCT116 cells.
Product SpecificationsWant a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
ab26 was shown to specifically react with p53 in wild type HCT116 cells treated with irinotecan. No band was observed in p53 knockout HCT116 cells. Wild-type and p53 knockout samples, positive and negative controls were subjected to SDS-PAGE. ab26 and Anti-GAPDH antibody [EPR16891] - Loading Control ab181602 (loading control to GAPDH) were diluted 5 μg/mL and 1/10,000 respectively and incubated overnight at 4°C. Blots were developed with goat anti-rabbit IgG (H + L) and goat anti-mouse IgG (H + L) secondary antibodies at 1/10,000 dilution for 1 h at room temperature before imaging.
Wild-type and p53 knockout HCT116 cell lysates were kindly provided by a collaborator.
All lanes: Western blot - Anti-p53 antibody [PAb 240] (ab26) at 5 µg/mL
Lane 1: Wild-type HCT116 cell lysate at 30 µg
Lane 2: Wild-type HCT116 + irinotecan (10 µM, 24 hours) cell lysate at 30 µg
Lane 3: p53 knockout HCT116 cell lysate at 30 µg
Lane 4: p53 knockout HCT116 + irinotecan (10 µM, 24 hours) cell lysate at 30 µg
Lane 5: A431 cell lysate (positive control) at 20 µg
Lane 6: Saos-2 cell lysate (negative control) at 20 µg
Performed under reducing conditions.
Predicted band size: 43 kDa
Observed band size: 53 kDa
All lanes: Western blot - Anti-p53 antibody [PAb 240] (ab26) at 1/2000 dilution
Lane 1: Human breast cancer cell-line, MCF7 cells (p53 WT), whole cell lysate at 20 µg
Lane 2: Human breast cancer cell-line, MDA231 cells (p53 Mutant), whole cell lysate at 20 µg
All lanes: HRP conjugated donkey anti-mouse antibody at 1/5000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 43 kDa
Observed band size: 53 kDa, 72 kDa
Exposure time: 10s
p53 was immunoprecipitated from 7x106 HCT116 (human colon carcinoma cell line) cells with ab26 at 1/150 dilution. Western blot was performed from the immunoprecipitate using anti-p53 antibody. Donkey Anti-Mouse IgG H&L (Alexa Fluor® 750) preadsorbed (Donkey Anti-Mouse IgG H&L (Alexa Fluor® 750) preadsorbed ab175739) was used as secondary antibody at 1/5000 dilution.
Lane 1: HCT116 whole cell lysate 10 μg (Input).
Lane 2: Anti-Adipose Triglyceride Lipase antibody [EPR19650] ab207799 IP in etoposide treated HCT116 whole cell lysate.
Lane 3: Anti-Adipose Triglyceride Lipase antibody [EPR19650] ab207799 IP in etoposide treated HCT116 p53-/- whole cell lysate (negative control).
All lanes: Anti p53 antibody
All lanes: Immunoprecipitation - Donkey Anti-Mouse IgG H&L (Alexa Fluor® 750) preadsorbed (Donkey Anti-Mouse IgG H&L (Alexa Fluor® 750) preadsorbed ab175739) at 1/5000 dilution
Predicted band size: 43 kDa
ab26 stained in A431 cells. Cells were fixed with 4% paraformaldehyde (10min) at room temperature and incubated with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% triton for 1h at room temperature to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with ab26 at 1μg/ml and Anti-beta Tubulin antibody - Loading Control ab6046 (Rabbit polyclonal to beta tubulin) at 1ug/ml overnight at +4°C. The secondary antibodies were Donkey Anti-Sheep IgG H&L (Alexa Fluor® 488) ab150177 (colored green) used at 1 ug/ml and Goat Anti-Rabbit IgG H&L (Alexa Fluor® 647) preadsorbed ab150087 (pseudo-colored red) used at 2ug/ml for 1hour at room temperature. DAPI was used to stain the cell nuclei (colored blue) at a concentration of 1.43μM for 1hour at room temperature.
This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab26 overnight at 4°C. Antibody binding was detected using an anti-mouse HRP secondary antibody (Goat Anti-Mouse IgG H&L (HRP) preadsorbed ab97040), and visualised using ECL development solution ECL Substrate Kit (High Sensitivity) ab133406.
All lanes: Western blot - Anti-p53 antibody [PAb 240] (ab26) at 1 µg/mL
All lanes: HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg
All lanes: Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (Goat Anti-Mouse IgG H&L (HRP) preadsorbed ab97040) at 1/50000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 43 kDa
Observed band size: 53 kDa
Exposure time: 8min
All lanes: Western blot - Anti-p53 antibody [PAb 240] (ab26) at 5 µg/mL
Lane 1: HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 20 µg
Lane 2: Hela Whole Cell Lysate - Bleomycin Treated (40U/ml) at 20 µg
All lanes: Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (Goat Anti-Mouse IgG H&L (HRP) preadsorbed ab97040) at 1/5000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 43 kDa
Exposure time: 4min
Lanes 1-2: 1% BSA blocking buffer
Lanes 3-4: 3% Milk blocking buffer
We recommend using 3% milk as the blocking agent for Western blot.
Lanes 1 - 2: Western blot - Anti-p53 antibody [PAb 240] (ab26) at 1 µg/mL
Lanes 3 - 4: Western blot - Anti-p53 antibody [PAb 240] (ab26) at 5 µg/mL
All lanes: HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 20 µg
All lanes: Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/5000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 43 kDa
Exposure time: 4min
Primary: All Lanes: Anti-p53 antibody (ab26) at 5 μg/mL. Lane 1: MW marker. Lane 2: NIH/3T3 cells treated with vehicle for 24 hours. Lane 3: NIH/3T3 cells treated with 1 μM doxorubicin for 24 hours Secondary: All Lanes: HRP-conjugated VeriBlot anti-Mouse IgG (Anti-mouse IgG for IP (HRP) ab131368) 1:1000. Lysates at 20 μg/lane. Performed under denaturing conditions. Developed using ECL technique. Blocking buffer: 5% milk in PBS.
All lanes: Western blot - Anti-p53 antibody [PAb 240] (ab26)
Predicted band size: 43 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com